
Sora Neuroscience is a medical technology company focused on improving brain patient care through resting-state fMRI technology. They develop software based on rigorous neuroscience and clinical investigation, aiming to integrate seamlessly with existing physician tools via open standards. Their goal is to empower physicians and patients with better information for informed decision-making. The company collaborates with Washington University in St. Louis (WashU) for technology licensing and clinical investigation, and with Prism Clinical Imaging for validation and commercialization. Sora Neuroscience emphasizes that none of their products are FDA authorized at this time.

Sora Neuroscience is a medical technology company focused on improving brain patient care through resting-state fMRI technology. They develop software based on rigorous neuroscience and clinical investigation, aiming to integrate seamlessly with existing physician tools via open standards. Their goal is to empower physicians and patients with better information for informed decision-making. The company collaborates with Washington University in St. Louis (WashU) for technology licensing and clinical investigation, and with Prism Clinical Imaging for validation and commercialization. Sora Neuroscience emphasizes that none of their products are FDA authorized at this time.
Headquarters: Minneapolis, Minnesota
Founded: 2020
Product: Cirrus — resting-state fMRI brain mapping software
Academic partner: Washington University in St. Louis (licensor/clinical investigator)
Clinical neuroimaging for surgical planning and brain patient care
2020
Biotechnology
3407500